Condition
Venlafaxine
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (1)
P 4 (1)
Trial Status
Unknown1
Recruiting1
Suspended1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07186751Not ApplicableRecruiting
The Efficacy and Safety of Pregabalin Combined With Venlafaxine in Patients With Fibromyalgia
NCT04973930Phase 3Suspended
Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer
NCT01204086Phase 4Unknown
Pharmacogenomics Studies of Antidepressants
Showing all 3 trials